Sandra Tillmann is a Principal Medical Writing Scientist at Johnson & Johnson, where they currently lead projects in scientific communication and drug development. They previously served as a Regulatory Writer at Novartis and have extensive experience in freelance scientific editing and medical writing, including roles at Compuscript Limited and LEO Pharma. Sandra earned a PhD in Neuroscience from Aarhus University and holds a Master of Science in Experimental and Clinical Neurosciences from the University of Regensburg. Their background also includes research assistance in translational neuropsychiatry and experience as a visiting PhD student.
This person is not in the org chart
This person is not in any teams
This person is not in any offices